메뉴 건너뛰기




Volumn 83, Issue 3, 1998, Pages 807-813

Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; BROMOCRIPTINE; BROMOCRIPTINE MESILATE; CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; FOLLITROPIN; LUTEINIZING HORMONE; OSTEOCALCIN; PROLACTIN; QUINAGOLIDE; TESTOSTERONE;

EID: 15644381530     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.83.3.4674     Document Type: Article
Times cited : (105)

References (29)
  • 2
    • 0020503695 scopus 로고
    • Bone density in amenorrheic women with and without hyperprolactinemia
    • Schlecthe JA, Sherman B, Martin R. 1983 Bone density in amenorrheic women with and without hyperprolactinemia. J Clin Endocrinol Metab. 56:1120-1123.
    • (1983) J Clin Endocrinol Metab , vol.56 , pp. 1120-1123
    • Schlecthe, J.A.1    Sherman, B.2    Martin, R.3
  • 3
    • 0021335114 scopus 로고
    • Decreased spinal mineral content in amenorrheic women
    • Cann CE, Martin MC, Genant HK, Jaffe RB. 1984 Decreased spinal mineral content in amenorrheic women. JAMA. 251:626-630.
    • (1984) JAMA , vol.251 , pp. 626-630
    • Cann, C.E.1    Martin, M.C.2    Genant, H.K.3    Jaffe, R.B.4
  • 4
    • 0021687231 scopus 로고
    • Vertebral body bone mineral content in hyperprolactinemic women
    • Koppelman MCS, Kurtz DW, Morrish KA, et al. 1984 Vertebral body bone mineral content in hyperprolactinemic women. J Clin Endocrinol Metab. 59:1050-1054.
    • (1984) J Clin Endocrinol Metab , vol.59 , pp. 1050-1054
    • Koppelman, M.C.S.1    Kurtz, D.W.2    Morrish, K.A.3
  • 5
    • 0023218330 scopus 로고
    • Forearm and vertebral bone mineral in treated and untreated hyperprolactinemic amenorrhea
    • Schlechte J, El-Khoury G, Kathol M, Walkner L. 1987 Forearm and vertebral bone mineral in treated and untreated hyperprolactinemic amenorrhea. J Clin Endocrinol Metab. 64:1021-1026.
    • (1987) J Clin Endocrinol Metab , vol.64 , pp. 1021-1026
    • Schlechte, J.1    El-Khoury, G.2    Kathol, M.3    Walkner, L.4
  • 8
    • 0022494409 scopus 로고
    • Increase in bone mass after treatment of hyperprolactinemic amenorrhea
    • Klibanski A, Greenspan SL. 1986 Increase in bone mass after treatment of hyperprolactinemic amenorrhea. N Engl J Med. 315:542-546.
    • (1986) N Engl J Med , vol.315 , pp. 542-546
    • Klibanski, A.1    Greenspan, S.L.2
  • 9
    • 0027246038 scopus 로고
    • Plasma calcitonin, IGF-I levels and vertebral bone mineral density in hyperprolactinemic women during bromocriptine treatment
    • Copenh
    • Toning O, Isberg B, Sjoberg HE, Bucht E, Hulting AL. 1993 Plasma calcitonin, IGF-I levels and vertebral bone mineral density in hyperprolactinemic women during bromocriptine treatment. Acta Endocrinol (Copenh). 128:423-427.
    • (1993) Acta Endocrinol , vol.128 , pp. 423-427
    • Toning, O.1    Isberg, B.2    Sjoberg, H.E.3    Bucht, E.4    Hulting, A.L.5
  • 12
    • 0022970639 scopus 로고
    • Symptomatic osteoporosis in a man with hyperprolactinemic hypogonadism
    • Jackson JA, Kleerekoper M, Parfitt M. 1986 Symptomatic osteoporosis in a man with hyperprolactinemic hypogonadism. Ann Intern Med. 105:543-545.
    • (1986) Ann Intern Med , vol.105 , pp. 543-545
    • Jackson, J.A.1    Kleerekoper, M.2    Parfitt, M.3
  • 13
    • 0024509604 scopus 로고
    • Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism
    • Greenspan SL, Oppenheim DS, Klibanski A. 1989 Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism. Ann Intern Med. 110:526-531.
    • (1989) Ann Intern Med , vol.110 , pp. 526-531
    • Greenspan, S.L.1    Oppenheim, D.S.2    Klibanski, A.3
  • 15
    • 0016240916 scopus 로고
    • Long-term treatment of galactorrhoea and hypogonadism with bromocriptine
    • Thorner MO, McNeilly AS, Hagan C, Besser GM. 1974 Long-term treatment of galactorrhoea and hypogonadism with bromocriptine. Br Med J. 2:419-422.
    • (1974) Br Med J , vol.2 , pp. 419-422
    • Thorner, M.O.1    McNeilly, A.S.2    Hagan, C.3    Besser, G.M.4
  • 16
    • 0021229948 scopus 로고
    • Return of gonadal function in men with prolactin-secreting pituitary tumors
    • Murray FT, Cameron DF, Ketchum C. 1984 Return of gonadal function in men with prolactin-secreting pituitary tumors. J Clin Endocrinol Metab. 59:79-85.
    • (1984) J Clin Endocrinol Metab , vol.59 , pp. 79-85
    • Murray, F.T.1    Cameron, D.F.2    Ketchum, C.3
  • 17
    • 0029905682 scopus 로고    scopus 로고
    • Chronic treatment with CV 205-502 restores the gonadal function in hyperprolactinemic males
    • Colao A, De Rosa M, Sarnacchiaro F, et al. 1996 Chronic treatment with CV 205-502 restores the gonadal function in hyperprolactinemic males. Eur J Endocrinol. 135:548-552.
    • (1996) Eur J Endocrinol , vol.135 , pp. 548-552
    • Colao, A.1    De Rosa, M.2    Sarnacchiaro, F.3
  • 19
    • 0027360117 scopus 로고
    • Prevalence and magnitude of osteopenia in patients with prolactinoma
    • Kayath MJ, Lengyel AM, Vieira JG. 1993 Prevalence and magnitude of osteopenia in patients with prolactinoma. Brazil J Med Biol Res. 26:933-941.
    • (1993) Brazil J Med Biol Res , vol.26 , pp. 933-941
    • Kayath, M.J.1    Lengyel, A.M.2    Vieira, J.G.3
  • 20
    • 0026783954 scopus 로고
    • A longitudinal analysis of premenopausal bone loss in healthy women and women with hyperprolactinemia
    • Schlechte J, Walkner L, Kathol M. 1992 A longitudinal analysis of premenopausal bone loss in healthy women and women with hyperprolactinemia. J Clin Endocrinol Metab. 75:698-703.
    • (1992) J Clin Endocrinol Metab , vol.75 , pp. 698-703
    • Schlechte, J.1    Walkner, L.2    Kathol, M.3
  • 21
    • 0030750108 scopus 로고    scopus 로고
    • Gonadal dysfunction in males with prolactinomas: From functional modification to irreversible damage?
    • Delgrange E, Donkier J. 1997 Gonadal dysfunction in males with prolactinomas: from functional modification to irreversible damage? Eur J Endocrinol. 136:630.
    • (1997) Eur J Endocrinol , vol.136 , pp. 630
    • Delgrange, E.1    Donkier, J.2
  • 23
    • 0024424879 scopus 로고
    • Castrated men exhibit bone loss: Effect of calcitonin treatment on biochemical indices of bone remodelling
    • Stepan JJ, Lachman M, Zverina J, Pacovsky V, Baylink DJ. 1989 Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodelling. J Clin Endocrinol Metab. 69:523-527.
    • (1989) J Clin Endocrinol Metab , vol.69 , pp. 523-527
    • Stepan, J.J.1    Lachman, M.2    Zverina, J.3    Pacovsky, V.4    Baylink, D.J.5
  • 25
    • 10244222400 scopus 로고    scopus 로고
    • Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men-a clinical research center study
    • Wang C, Eyre DR, Clark D, et al. 1996 Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men-a clinical research center study. J Clin Endocrinol Metab. 81:3654-3662.
    • (1996) J Clin Endocrinol Metab , vol.81 , pp. 3654-3662
    • Wang, C.1    Eyre, D.R.2    Clark, D.3
  • 27
    • 0022374775 scopus 로고
    • Prediction of postmenopausal fracture risk with use of bone mineral measurements
    • Wasnich RD, Ross PD, Heilbrun LK, Vogel JM. 1985 Prediction of postmenopausal fracture risk with use of bone mineral measurements. Am J Obset Gynecol. 153:745-751.
    • (1985) Am J Obset Gynecol , vol.153 , pp. 745-751
    • Wasnich, R.D.1    Ross, P.D.2    Heilbrun, L.K.3    Vogel, J.M.4
  • 28
    • 0024458249 scopus 로고
    • Baseline measurement of bone mass predicts fracture in white women
    • Hui SL, Slemenda CW, Johnston Jr CC. 1989 Baseline measurement of bone mass predicts fracture in white women. Ann Intern Med. 111:355-361.
    • (1989) Ann Intern Med , vol.111 , pp. 355-361
    • Hui, S.L.1    Slemenda, C.W.2    Johnston Jr., C.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.